Loading...

Brefeldin A Solution (1,000X)

Pricing & Availability
Regulatory Status
RUO
Other Names
BFA
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420601 1 mL 52€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Brefeldin A (BFA) is a protein transport inhibitor commonly used to enhance intracellular cytokine staining signals by blocking transport processes during cell activation. Especially useful for the intracellular staining of cytokines, BFA leads to the accumulation of most cytokines at the Golgi Complex/Endoplasmic Reticulum (see Jung, et al., 1993). Optimal conditions for use are cell type and time-dependent. Typically, protein transport inhibitors are included during in vitro cell activation cultures for 4-24 hours prior to harvest (see references below for additional information). Brefeldin A Solution is supplied as a 1,000X solution, which should be diluted to 1X in cell culture medium.

Product Details
Technical Data Sheet (pdf)

Product Details

Formulation
Brefeldin A Solution is supplied as a 1000X in DMSO, which should be diluted to 1X in cell culture medium.
Concentration
5.0 mg/ml
Storage & Handling
Store the Brefeldin A Solution (1,000X) between 2°C and 8°C. Note: DMSO freezes at this temperature.
Application

ICFC - Quality tested
Recommended Usage

Dilute the 1000X solution to 1X in the tissue culture medium. It is recommended that cells are cultured with brefeldin A for ≤ 24 hours, as this can become toxic for cell viability.

Application Notes

Completely thaw the solution before use, DMSO freezes at 4°C.  We recommend aliquotting the reagent into smaller volumes to avoid repeated freeze-thawing.  

Application References
  1. O'Sullivan BJ, et al. 2006. J. Immunol. 176:7278.
  2. Fuse S, et al. 2007. J. Immunol. 178:5227.
  3. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  4. Redfern CH,et al.2006.J. Clin Oncol.19:3107. PubMed
  5. Smithey MJ, et al. 2008. J. Immunol. 180:3406. PubMed
  6. Elzey BD, et al. 2008. Blood 111:38684. PubMed
  7. Nguyen KD, et al. 2008. J. Immunol. 181:5386. PubMed
  8. Miner MD, et al. 2008. Microb Pathog. 45:273. PubMed
  9. Goodridge HS, et al. 2009. J. Immunol. 182:1146. PubMed
  10. Markey KA, et al. 2009. Blood 113:5644. PubMed
  11. Wilcox RA, et al. 2009. Blood PubMed
  12. Zenaro E, et al. 2009. J. Leukoc Bio. PubMed
  13. Rozkova D, et al. 2009. Clin Immunol. 131:1. PubMed
  14. Butcher JP, et al. 2010. Clin Cancer Res. 16:2065.
  15. Boisvert M, et al. 2010. J. Virol. 84:7782. PubMed
  16. Liu WC, et al. 2010. J. Virol. 84:12011.15. Tawara I, et al. 2011. Clin Cancer Res. 17:77. PubMed
  17. Iwata Y, et al. 2011. Blood. 117:530. PubMed
  18. Schmidt NW, et al. 2011. J. Immunol. 186:3836. PubMed
  19. Langkjaer A, et al. 2012. Clin Immunol. 145:1. PubMed
  20. Molinero LL, et al. 2012. PNAS. 109:18529. PubMed
  21. Li HW, et al. 2012. J. Immunol. 189:5572. PubMed
  22. Wang JM, et al. 2013. J. Virol. 87:4372. PubMed
  23. Fukuoka A, et al. 2013. Int Immunol. 25:373. PubMed
  24. Wang Jm, et al. 2013. J Virol. 87:11626. PubMed
  25. Lee TH, et al. 2013. J Biol Chem. 288:32873. PubMed
  26. Shi L, et al. 2014. J. Immunol. 192:649. PubMed
  27. Bulati M, et al. 2014. Exp Gerontol. PubMed
  28. Blankenhaus B, et al. 2014. PLoS Pathog. 10:1003913. PubMed
  29. Tuna H, et al. 2014. J Leukoc Biol. 95:471. PubMed
  30. Miller ML, et al. 2014. PNAS. 111:7397. PubMed
  31. Wang Y, et al. 2014. Sci Rep. 4:5346. PubMed
  32. Zhou GL, et al. 2014. J Cell Sci. 127:3916. PubMed
  33. Rist MJ, et al. 2015. J Virol. 89:703. PubMed
Product Citations
  1. Wang Y, et al. 2014. Sci Rep. 4:5346. PubMed
  2. Morse M, et al. 2016. Lupus. 25: 81 - 87. PubMed
  3. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  4. Wang R, et al. 2018. Oncoimmunology. 7:e1461303. PubMed
  5. Persaud AT, et al. 2022. J Leukoc Biol. 111:573. PubMed
  6. Yu L, et al. 2022. FEBS J. 289:3241. PubMed
  7. Ritzel RM, et al. 2022. Geroscience. 44:1407. PubMed
  8. D'Angeli V, et al. 2022. Eur J Immunol. 52:1058. PubMed
  9. Lu R, et al. 2022. Scand J Immunol. 96:e13177. PubMed
  10. Kanbar JN, et al. 2022. J Exp Med. 219: . PubMed
  11. Minichino D, et al. 2022. J Leukoc Biol. 112:1089. PubMed
  12. Gao KM, et al. 2022. Proc Natl Acad Sci U S A. 119:e2202327119. PubMed
  13. Liu H, et al. 2022. Cell Rep Med. 3:100660. PubMed
  14. Jondle CN, et al. 2022. J Virol. 96:e0063922. PubMed
  15. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  16. Hsieh T, et al. 2022. Front Immunol. 13:901030. PubMed
  17. Li FL, et al. 2022. EMBO J. 41:e110698. PubMed
  18. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  19. Dutt TS, et al. 2022. Cell Rep. 41:111783. PubMed
  20. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  21. Shamriz O, et al. 2023. Front Immunol. 13:1044933. PubMed
  22. Chan L, et al. 2022. Cells. 12: . PubMed
  23. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  24. Nanishi E, et al. 2023. NPJ Vaccines. 8:18. PubMed
  25. Hajjar S, et al. 2022. Cell Death Differ. 29:585. PubMed
  26. Li Y, et al. 2022. Brain Behav Immun. 101:1. PubMed
  27. Zander R, et al. 2022. Immunity. 55:475. PubMed
  28. Pymm P, et al. 2022. Cell Rep. 38:110449. PubMed
  29. Giles JR, et al. 2022. Immunity. 55:557. PubMed
  30. Ye L, et al. 2022. Cell Metab. 34:595. PubMed
  31. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  32. Zhao Y, et al. 2022. ACS Appl Mater Interfaces. 14:21872. PubMed
  33. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  34. Sun Y, et al. 2022. STAR Protoc. 3:101479. PubMed
  35. Redelman-Sidi G, et al. 2022. Cancer Immunol Res. 10:1241. PubMed
  36. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  37. Lao L, et al. 2023. Cancer Immunol Res. 11:320. PubMed
  38. Zhao Q, et al. 2023. Signal Transduct Target Ther. 8:40. PubMed
  39. Yang WL, et al. 2023. Nat Commun. 14:863. PubMed
  40. Wu Z, et al. 2023. EMBO Rep. 24:e56524. PubMed
  41. Li G, et al. 2023. Cell Death Dis. 14:185. PubMed
  42. Kozlovski S, et al. 2023. Front Immunol. 13:1041552. PubMed
  43. Mohammadpour H, et al. 2023. Cell Rep. 42:112250. PubMed
  44. Jung HY, et al. 2023. Oncoimmunology. 12:2190671. PubMed
  45. Li Y, et al. 2023. Vaccines (Basel). 11:. PubMed
  46. Onyshchenko K, et al. 2023. Nat Commun. 14:2087. PubMed
  47. Zhou X, et al. 2023. Sci Rep. 13:6701. PubMed
  48. Ko ES, et al. 2023. Cell Commun Signal. 21:107. PubMed
  49. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  50. Thomas OG, et al. 2023. Sci Adv. 9:eadg3032. PubMed
  51. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  52. Adamo S, et al. 2023. Cell Host Microbe. 31:928. PubMed
  53. LaPorte KM, et al. 2023. J Immunother Cancer. 11:. PubMed
  54. Patskovsky Y, et al. 2023. Nat Commun. 14:3763. PubMed
  55. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  56. Yakkala C, et al. 2021. Front Immunol. 12:695150. PubMed
  57. Zheng B, et al. 2021. Int J Mol Sci. 22: . PubMed
  58. Alexander KL, et al. 2021. Gastroenterology. 161:522. PubMed
  59. Trinks N, et al. 2021. Commun Biol. 4:1151. PubMed
  60. Chen J, et al. 2022. Adv Healthc Mater. 11:e2101714. PubMed
  61. Pablo-Bernal R, et al. 2016. J Gerontol A Biol Sci Med Sci. 71: 610 - 618. PubMed
  62. Tuna H, et al. 2014. J Leukoc Biol. 95:471. PubMed
  63. Zhu S, et al. 2017. Exp Cell Res.. 10.1016/j.yexcr.2017.10.013. PubMed
  64. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  65. Aguilar-Pineda JA, et al. 2021. iScience. 24:102993. PubMed
  66. Moudra A, et al. 2021. J Immunol. 206:2109. PubMed
  67. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  68. Xin G, et al. 2021. Cancer Immunol Res. 9:454. PubMed
  69. Rodrigues M, et al. 2022. Biochem J. 479:1891. PubMed
  70. Nesterenko PA, et al. 2021. Cell Rep. 37:110167. PubMed
  71. Lefebvre MN, et al. 2021. Cell Rep. 37:109956. PubMed
  72. Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
  73. Fote GM, et al. 2022. J Cell Sci. 135:. PubMed
  74. Shi L, et al. 2014. J Immunol. 192:649. PubMed
  75. Yamamoto A, et al. 2019. J Clin Invest. 129:3640. PubMed
  76. Maschmeyer P, et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.11.005. PubMed
  77. Weng RR, et al. 2021. Nat Commun. 12:2163. PubMed
  78. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  79. Just S, et al. 2016. Sci Rep. 6:39796. PubMed
  80. Piper CJM, et al. 2020. Cell Reports. 29(7):1878-1892.e7.. PubMed
  81. Gay MD, et al. 2020. Cancer Prev Res (Phila). . PubMed
  82. Liang Q, et al. 2022. iScience. 25:104043. PubMed
  83. Cook CP, et al. 2022. Cell Rep Med. 3:100715. PubMed
  84. Snyder LM, et al. 2021. PLoS Pathog. 17:e1009970. PubMed
  85. Krone A, et al. 2022. Sci Rep. 218:. PubMed
  86. Michaud D, et al. 2022. Front Immunol. 12:745873. PubMed
  87. Nagatake T, et al. 2022. Mucosal Immunol. 15:289. PubMed
  88. Starnbach X 2015. J Immunol. 195: 1665-1675. PubMed
  89. Garg B, et al. 2016. Mutagenesis. 10.1093/mutage/gew023. PubMed
  90. Ruhland M, et al. 2016. Nat Commun. 7:11762. PubMed
  91. Nguyen K, et al. 2008. J Immunol. 181:5386. PubMed
  92. Wilcox R, et al. 2009. Blood. 114:2936. PubMed
  93. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  94. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  95. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  96. Almshayakhchi R, et al. 2021. Front Oncol. 11:636977. PubMed
  97. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  98. Griffiths K, et al. 2016. Nat Commun. 7:13894. PubMed
  99. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  100. Al-Attar A, et al. 2016. Data Brief. 8: 536-44. PubMed
  101. Gonzalez-Perez G, et al. 2016. J Immunol. 196: 3768 - 3779. PubMed
  102. Pablo-Bernal R, et al. 2015. J Infect Dis. 10.1093/infdis/jiv520. PubMed
  103. Blankenhaus B, et al. 2014. PLoS Pathog. 10:1003913. PubMed
  104. Smithey M, et al. 2008. J Immunol. 180:3406. PubMed
  105. Rana A, et al. 2020. Front Immunol. 11:536. PubMed
  106. Dayoub O, et al. 2017. Sci Rep. 10.1038/s41598-017-09933-4. PubMed
  107. Kang X, et al. 2022. Vaccines (Basel). 10:. PubMed
  108. Jeong J, et al. 2021. Immune Netw. 21:e31. PubMed
  109. Jondle CN, et al. 2021. MBio. 12:. PubMed
  110. Martens A, et al. 2020. Nat Immunol. 21:381. PubMed
  111. Wang Z, et al. 2020. Autophagy. 1:. PubMed
  112. Jiang S, et al. 2020. Scand J Immunol. e12867:91. PubMed
  113. Hradilova N, et al. 2017. PLoS One. 12(2):e0171539. PubMed
  114. Doll K, et al. 2016. J Immunol. 196: 4253 - 4262. PubMed
  115. Liu W, et al. 2016. J Virol. 90: 6085 - 6096. PubMed
  116. Fucikova J, et al. 2016. Blood. 128(26):3113-3124. PubMed
  117. Yu H, et al. 2011. J Leukoc Biol. 90:205. PubMed
  118. Zhao F, et al. 2022. Front Immunol. 13:873720. PubMed
  119. Douthwaite J, et al. 2017. J Immunol. 198(1):528-537. PubMed
  120. Snyder LM, et al. 2022. Immunohorizons. 6:660. PubMed
  121. Rialdi A, et al. 2016. Science. 352: aad7993. PubMed
  122. Li H, et al. 2012. J Immunol. 189:5572. PubMed
  123. Liu W, et al. 2010. J Virol. 84:12011. PubMed
  124. Elzey B, et al. 2008. Blood. 111:3684. PubMed
  125. Ries M, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006506. PubMed
  126. Satoh M, et al. 2016. Sci Rep. 6:28473. PubMed
  127. Carissimo G, et al. 2019. Life Sci Alliance. 2:e201900298. PubMed
  128. Wang Y, et al. 2020. Sci Adv. 6:eaba5412. PubMed
  129. Uddin MN, et al. 2022. Brain Behav Immun Health. 26:100563. PubMed
  130. Codo AC, et al. 2020. Cell Metab. 32:437. PubMed
  131. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  132. Shenoy AT, et al. 2021. Nat Commun. 12:5834. PubMed
  133. Ulrich-Lewis JT, et al. 2022. Front Immunol. 13:861710. PubMed
  134. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  135. Dumaine JE, et al. 2021. Elife. 10:. PubMed
  136. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  137. Jondle CN, et al. 2021. J Virol. 95:e0072621. PubMed
  138. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  139. Gross C, et al. 2016. Neurol Neuroimmunol Neuroinflamm. 3: e289. PubMed
  140. Krämer B, et al. 2016. PLoS One. 11: 0162068. PubMed
  141. Tawara I, et al. 2011. Clin Cancer Res. 0.761805556. PubMed
  142. Orlov M, et al. 2017. PLoS One.. 10.1371/journal.pone.018296. PubMed
  143. Martins M, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006529. PubMed
  144. Crooks SD, et al. 2022. Immunohorizons. 6:705. PubMed
  145. Fang E, et al. 2022. MedComm (2020). 3:e117. PubMed
  146. Lee T, et al. 2013. J Biol Chem. 288:32873. PubMed
  147. Vigano S, et al. 2015. J Virol. 89: 7829-7840. PubMed
  148. Vacaflores A, et al. 2016. PLoS One. 11: 0157175. PubMed
  149. Ma H, Wan S, Xia C 2016. J Leukoc Biol. 99: 1121 - 1129. PubMed
  150. Kim J, et al. 2016. Nat Immunol. 17:1159-1166. PubMed
  151. Hassan AO, et al. 2020. Cell. 183:169. PubMed
  152. Harty N 2011. J Immunol. 186:3836. PubMed
  153. Iwata Y, et al. 2011. Blood. 117:530. PubMed
  154. Cao Y, et al. 2018. Nat Commun. 2.940972222. PubMed
  155. Emmer BT, et al. 2018. Elife. 7:e38839. PubMed
  156. Johnson AM, et al. 2020. J Immunol. 204:2295. PubMed
  157. Buqué A, et al. 2020. Nat Commun. 3.110416667. PubMed
  158. Matisz C, et al. 2017. Sci Rep. 7:40631. PubMed
  159. Castro I, et al. 2016. J Virol. 90: 5280 - 5291. PubMed
  160. Zhang W, et al. 2015. Infect Immun . 83: 3213-3223. PubMed
  161. Ji L, et al. 2012. PLoS One. 7:e50909. PubMed
  162. Redfern C, et al. 2006. J Clin Oncol. 24:3107. PubMed
  163. Yan H, et al. 2020. ACS Appl Mater Interfaces. 12:19324. PubMed
  164. Huang RS, et al. 2021. Curr Protoc. 1:e246. PubMed
  165. Li G, et al. 2021. Curr Protoc. 1:e50. PubMed
  166. Gao Y, et al. 2022. Immunity. 55:1732. PubMed
  167. Han K, et al. 2021. Nat Metab. 3:318. PubMed
  168. Peng L, et al. 2022. Cell Rep Med. 3:100634. PubMed
  169. Bachy S, et al. 2022. iScience. 25:103758. PubMed
  170. Ohtsuka J, et al. 2021. iScience. Online ahead of print. PubMed
  171. Nice T, et al. 2016. PLoS One. 12: 1005684. PubMed
  172. Pfeifle R, et al. 2016. Nat Immunol. 18:104-113. PubMed
  173. Ngwenyama N, et al. 2019. JCI Insight. 4:e125527. PubMed
  174. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  175. Butchar J, et al. 2010. Clin Cancer Res. 2.100694444. PubMed
  176. Wang J, et al. 2013. J Virol. 87:4372. PubMed
  177. Krishnan A, et al. 2020. Am J Pathol. 190:1284. PubMed
  178. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  179. Grace PS, et al. 2021. Front Immunol. 12:679973. PubMed
  180. Li Y, et al. 2021. Vaccines (Basel). 9:. PubMed
  181. Liu W, et al. 2022. Bio Protoc. 12:e4285. PubMed
  182. Ma K, et al. 2022. iScience. 25:104347. PubMed
  183. Zhang Y, et al. 2022. Vaccines (Basel). 10: . PubMed
  184. Matsushita T, et al. 2015. Rheumatology. 101093/rumatology/kv331. PubMed
  185. Molinero L, et al. 2012. Proc Natl Acad Sci U S A. 109:18529. PubMed
  186. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  187. Sekine T, et al. 2020. Cell. 183:158. PubMed
  188. Gogokhia L, et al. 2019. Cell Host Microbe. 25:285. PubMed
  189. Guo C, et al. 2018. Immunity. 49:842. PubMed
  190. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  191. Rossato C, et al. 2017. Biologicals. 10.1016/j.biologicals.2017.06.007. PubMed
  192. Tajima M, et al. 2022. Curr Protoc. 2:e540. PubMed
  193. Stepanova E, et al. 2021. Microorganisms. 9:. PubMed
  194. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  195. Loeuillard E, et al. 2020. J Clin Invest. 130:5380. PubMed
  196. de Picciotto S, et al. 2022. Nat Commun. 13:3866. PubMed
  197. Michelozzi IM, et al. 2022. STAR Protoc. 3:101174. PubMed
  198. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  199. Rozková D, et al. 2009. Clin Immunol. 131:1. PubMed
  200. Miner M, et al. 2008. Microb Pathog. 45:273. PubMed
  201. Miller M, et al. 2014. Proc Natl Acad Sci U S A. 111:7397. PubMed
  202. Gartlan K, et al. 2015. Blood. 126: 1609-1620. PubMed
  203. Ulland T, et al. 2016. Nat Commun. 7:13180. PubMed
  204. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  205. Rosser EC, et al. 2020. Cell Metabolism. 31(4):837-851. PubMed
  206. Zenaro E, et al. 2009. J Leukoc Biol. 86:1393. PubMed
  207. Goodridge H, et al. 2009. J Immunol. 182:1146. PubMed
  208. Gnerlich J, et al. 2010. J Immunol. 185:4063. PubMed
  209. Boisvert M, et al. 2010. J Virol. 84:7782. PubMed
  210. Langkjær A, et al. 2012. Clin Immunol. 145:1. PubMed
  211. Melacarne A, et al. 2021. Cell Reports. 36(1):109312. PubMed
  212. Tse SW, et al. 2021. Mol Ther. 29:2227. PubMed
  213. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  214. Beyaz S, et al. 2016. Nat Immunol. 18:184-195. PubMed
  215. Kadivar M, et al. 2016. J Immunol. 197(12):4584-4592. PubMed
  216. Wang J, et al. 2013. J Virol. 87:11262. PubMed
  217. Markey K, et al. 2009. Blood. 113:5644. PubMed
  218. Salazar V, et al. 2019. Cell Rep. 26:1585. PubMed
  219. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  220. Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed
  221. Virtakoivu R, et al. 2021. Clin Cancer Res. 27:4205. PubMed
  222. Koschel J, et al. 2021. Cell Death Differ. 28:2257. PubMed
  223. FitzPatrick MEB, et al. 2021. Cell Rep. 34:108661. PubMed
  224. Bass VL, et al. 2021. Mol Syst Biol. 17:e10127. PubMed
  225. Theisen U, et al. 2020. J Cell Biol. :219. PubMed
  226. Dáňová K, et al. 2017. J Immunol. 198(2):729-740. PubMed
  227. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  228. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  229. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  230. Li Z, et al. 2021. JCI Insight. 6:. PubMed
  231. Bulati M, et al. 2014. Exp Gerontol. 54:123. PubMed
  232. Zhou G, et al. 2014. J Cell Sci. 127:3916. PubMed
  233. Rist M, et al. 2015. J Virol. 89:703. PubMed
  234. Hoechst B, et al. 2016. J Immunol. 195:1517-1523. PubMed
  235. Fukuoka A, et al. 2013. Int Immunol. 25:373. PubMed
  236. Landi A, et al. 2017. Vaccine.. 10.1016/j.vaccine.2017.10.072. PubMed
  237. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  238. Mohammadpour H, et al. 2020. JCI Insight. 5:00. PubMed
  239. Gussarow D, et al. 2021. Front Med (Lausanne). 8:770381. PubMed
  240. Mackroth M, et al. 2016. PLoS Pathog. 12:e1005909. PubMed
  241. Rau M, et al. 2016. J Immunol. 196: 97 - 105. PubMed
  242. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  243. Genardi S, et al. 2020. Front Immunol. 11:610010. PubMed
  244. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  245. Kohn M, et al. 2021. Front Immunol. 626627:12. PubMed
  246. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  247. Olafsdottir TA, et al. 2022. Commun Biol. 5:914. PubMed
  248. Lei Y, et al. 2021. Sci Adv. 7:. PubMed
  249. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  250. Krishna B, et al. 2016. Sci Rep. 6: 24674. PubMed
  251. Ruland C, et al. 2017. Brain Behav Immun. 10.1016/j.bbi.2017.06.010. PubMed
  252. Ahmadi H,et al. 2017. Inflammopharmacology. . 10.1007/s10787-017-0410-8. PubMed
  253. Li J, et al. 2018. Redox Biol. 0.976388889. PubMed
  254. Schridde A, et al. 2017. Mucosal Immunol. 10.1038/mi.2016.142. PubMed
  255. Wang W, et al. 2020. STAR Protoc. 1:100218. PubMed
  256. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  257. Abshire C, et al. 2016. PLoS Pathog. 12:e1006088. PubMed
  258. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  259. Lu G, et al. 2017. PLoS One. 12:e0178352. PubMed
  260. Orozco SL, et al. 2019. Cell Rep. 28:2275. PubMed
  261. Matei DE, et al. 2021. Med (N Y). 2:864. PubMed
  262. Laczkó D, et al. 2020. Immunity. 53:724. PubMed
  263. Ying B, et al. 2022. Sci Transl Med. 14:eabm3302. PubMed
  264. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  265. Carrion B, et al. 2021. Neurol Neuroimmunol Neuroinflamm. 8:. PubMed
  266. Petrova T, et al. 2021. FEBS J. 288:5909. PubMed
  267. Nesterenko PA, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.
5. Jung T, et al. 1993. J. Immunol. Meth. 159:197.

Gene ID
NA

Related FAQs

The Brefeldin A solution freezes at 4°C . Is the solution still OK?

We recommend to thaw in warm water after removing from the fridge.  The Brefeldin A is dissolved in DMSO, which freezes at 18°C, so this is normal.  No one has reported any problems with the freeze/thaw cycles and this is how we recommend it is stored.   If customers are concerned, they can aliquot the Brefeldin A to avoid the freeze thaw.

How do I choose monensin or Brefeldin A solution?

Generally, Brefeldin A is more toxic for longer term incubations, so for shorter stimulations (6 hrs or less) use Brefeldin A.  For longer stimulations use monensin.  We recommend optimization for each cell type and protocol.

Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account